Downloads

  1. From Path Dependency To Demonstrable Progress: FDA Modernization Act 3.0 7/23/2026

    With House passage of the FDA Modernization Act 3.0, Congress has taken another major step toward modernizing biomedical research and drug development.

  2. How AI-Powered Automation Is Redefining Pharmaceutical R&D 7/23/2026

    The autonomous lab is not a distant aspiration but a present-day competitive differentiator.

  3. Rethinking The Blueprint For Bone Regeneration: The Next Evolution In Orthobiologics 7/22/2026

    Next-generation orthobiologics could transform spinal fusion by enabling targeted bone regeneration, improving safety, and reducing reliance on traditional grafts and hardware.

  4. Pharmacogenomics In Oncology: A Pharmacokinetic Perspective 7/22/2026

    The outcome of a medical treatment is not solely determined by the efficacy of the drug itself. It also depends on the patient’s genetic makeup, biological characteristics of the disease, and individual clinical factors.

  5. From Valency To Vaccine Design: The Changing Competitive Landscape In Pneumococcal Vaccines 7/21/2026

    Pneumococcal vaccination remains one of the strongest success stories in bacterial disease prevention, but the residual burden is now posing new challenges. 

  6. Can We Cure Diabetes? 7/15/2026

    We caught up with Minutia CEO Katy Digovich to discuss engineered iPSC-derived islets intended for transplantation into the forearm, which could make a functional cure for insulin-dependent diabetes broadly accessible.

  7. Botanical Therapeutics For CNS Disorders 7/7/2026

    We caught up with Joel Stanley, founder and CEO of AJNA Biosciences, to talk about botanical drug development.

  8. Wondering If Your Org Should Purchase R&D Datasets? 7/1/2026

    Pharma/biotech companies are increasingly looking to access large-scale data sets to fill gaps in their computational biology capabilities. Be prepared for the investment.

  9. Residual DNA Testing Across Biotherapeutics 6/30/2026

    Residual host cell DNA testing can create bottlenecks. Learn how digital PCR supports more consistent quantification, simpler method deployment, and faster in-process and lot release decisions.

  10. Organ-On-A-Chip Technology Unlocks Patient-Derived Precision Medicine 6/25/2026

    Personalized medicine struggles with models that fail to reflect real human biology. Organ-on-a-Chip systems recreate tissue complexity, helping predict patient-specific treatment responses.